RU93037416A - USE OF IZOXASOL DERIVATIVES FOR THE TREATMENT OF THE SYNDROME OF THE IRRITATION OF A THICK INTESTINUM (MULTIUS COLITIS) AND PHARMACEUTICAL COMPOSITION - Google Patents

USE OF IZOXASOL DERIVATIVES FOR THE TREATMENT OF THE SYNDROME OF THE IRRITATION OF A THICK INTESTINUM (MULTIUS COLITIS) AND PHARMACEUTICAL COMPOSITION

Info

Publication number
RU93037416A
RU93037416A RU93037416/14A RU93037416A RU93037416A RU 93037416 A RU93037416 A RU 93037416A RU 93037416/14 A RU93037416/14 A RU 93037416/14A RU 93037416 A RU93037416 A RU 93037416A RU 93037416 A RU93037416 A RU 93037416A
Authority
RU
Russia
Prior art keywords
treatment
derivatives
multius
izoxasol
intestinum
Prior art date
Application number
RU93037416/14A
Other languages
Russian (ru)
Other versions
RU2127111C1 (en
Inventor
Сингх Гидда Джесвонт
Менерт Скаус Джон
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of RU93037416A publication Critical patent/RU93037416A/en
Application granted granted Critical
Publication of RU2127111C1 publication Critical patent/RU2127111C1/en

Links

Claims (1)

Предлагаемый способ лечения синдрома раздражения толстой кишки предусматривает применение ряда изоксазол-производных, обладающих агонистической активностью для 5-НТIА и МI-мускарина, а также содержащих их фармацевтических составов.The proposed method for the treatment of irritable bowel syndrome involves the use of a number of isoxazole derivatives, which possess agonistic activity for 5-HTIA and MI muscarin, as well as pharmaceutical formulations containing them.
RU93037416A 1992-07-17 1993-07-15 Use of isoxazole derivatives for treatment of patients with irritable bowel syndrome (mucous colitis) and a pharmaceutical composition RU2127111C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91628192A 1992-07-17 1992-07-17
US07/916,281 1992-07-17

Publications (2)

Publication Number Publication Date
RU93037416A true RU93037416A (en) 1996-03-20
RU2127111C1 RU2127111C1 (en) 1999-03-10

Family

ID=25436992

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93037416A RU2127111C1 (en) 1992-07-17 1993-07-15 Use of isoxazole derivatives for treatment of patients with irritable bowel syndrome (mucous colitis) and a pharmaceutical composition

Country Status (23)

Country Link
US (1) US5434174A (en)
EP (1) EP0579507B1 (en)
JP (1) JPH06166620A (en)
CN (1) CN1049336C (en)
AT (1) ATE206918T1 (en)
AU (1) AU666377B2 (en)
CA (1) CA2100399A1 (en)
CZ (1) CZ284881B6 (en)
DE (1) DE69330926T2 (en)
DK (1) DK0579507T3 (en)
ES (1) ES2162808T3 (en)
HK (1) HK1013795A1 (en)
HU (1) HUT68727A (en)
IL (1) IL106307A (en)
MX (1) MX9304205A (en)
NO (1) NO304054B1 (en)
PH (1) PH30148A (en)
PL (1) PL172494B1 (en)
PT (1) PT579507E (en)
RU (1) RU2127111C1 (en)
TW (1) TW232653B (en)
UA (1) UA27720C2 (en)
ZA (1) ZA934969B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7048906B2 (en) * 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US5962488A (en) 1998-04-08 1999-10-05 Roberts Laboratories, Inc. Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
US6541669B1 (en) * 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
FR2792529B1 (en) * 1999-04-26 2001-09-28 Sod Conseils Rech Applic NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING 2-ISOXAZOLE-8-AMINOTETRALINE DERIVATIVES
UA76130C2 (en) * 2000-11-20 2006-07-17 Merck Patent Gmbh Use of compounds combining properties of selective inhibitors of serotonin re-uptake and agonists of 5-ht1a receptor for treatment of irritable bowel syndrome
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040147581A1 (en) * 2002-11-18 2004-07-29 Pharmacia Corporation Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
WO2004062623A2 (en) * 2003-01-13 2004-07-29 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
SE0301796D0 (en) * 2003-06-19 2003-06-19 Astrazeneca Ab New use II
SE0301798D0 (en) * 2003-06-19 2003-06-19 Astrazeneca Ab New use IV
SE0301795D0 (en) * 2003-06-19 2003-06-19 Astrazeneca Ab New use I
SE0301794D0 (en) * 2003-06-19 2003-06-19 Astrazeneca Ab New use III
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
US7684402B2 (en) 2006-05-15 2010-03-23 Faraday Technology Corp. Method and network device for fast look-up in a connection-oriented communication
CN104884064A (en) 2012-12-24 2015-09-02 纽洛佳斯特拉斯公司 Methods for treating gi tract disorders
WO2015200369A1 (en) 2014-06-24 2015-12-30 Neurogastrx, Inc. Prodrugs of metopimazine
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK203089A (en) * 1988-04-28 1989-10-29 Beecham Group Plc metabolites
HUT61719A (en) * 1989-05-31 1993-03-01 Upjohn Co Process for producing 2-aminotetraline derivatives and pharmaceutical compositions comprising such compounds
SE8904361D0 (en) * 1989-12-22 1989-12-22 Astra Ab NEW CHROMAN AND THIOCHROMAN DERIVATIVES
US5158956A (en) * 1990-05-04 1992-10-27 Eli Lilly And Company Method of inhibiting gastric acid secretion with benzodioxanes
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
ZA92767B (en) * 1991-02-08 1993-08-03 Lilly Co Eli Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes and 3-aminochromanes.

Similar Documents

Publication Publication Date Title
RU93037416A (en) USE OF IZOXASOL DERIVATIVES FOR THE TREATMENT OF THE SYNDROME OF THE IRRITATION OF A THICK INTESTINUM (MULTIUS COLITIS) AND PHARMACEUTICAL COMPOSITION
ZA872867B (en) 5-arylalkyl-4-alkoxy-2(5h)-furanones,intermediates and processes for the preparation thereof and pharmaceutical compositions containing them
GB8826066D0 (en) New use of 11 28-dioxa-4-azatricyclo(22 3 1 0 4.9)octacos-18-ene derivatives & pharmaceutical compositions
DE68908786D1 (en) Condensed pyrimidine derivatives, processes and intermediates for their preparation and pharmaceutical preparations containing them.
OA08581A (en) Treatment of diseases caused by retroviruses.
IL67572A (en) Trans-2-aza bicyclo(3.(3+n).o)alkane-3-carboxylic acid derivatives,processes for their preparation and pharmaceutical compositions containing them
DE2862419D1 (en) Derivatives of 7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid, their preparation, pharmaceutical compositions containing them and intermediates
RU93004445A (en) NEW 2-CYANO 3-HYDROXYENAMIDE DERIVATIVES, METHOD FOR THEIR RECEPTION, THEIR APPLICATION AS MEDICATION, CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND NEW OBTAINED INTERMEDIATE
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
FI903153A0 (en) 11B-ARYL-4-ESTRENER, FOERFARANDE FOER DERAS FRAMSTAELLNING SAMT DERAS ANVAENDNING SOM LAEKEMEDEL.
IT1190824B (en) PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
ZA9110018B (en) 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity.
ATE56956T1 (en) (S)-(-)-1-PROPYL-2',6'-PIPECOLOXYLIDIDE HYDROCHLORIDE MONOHYDRATE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL PREPARATION CONTAINING IT.
TR26643A (en) NEW COMPONENTS, PROCESSES FOR THE PREPARATION OF THEM, THEIR COMPOSITIONS AND THEIR USE AS HERBISIDES.
AU7116781A (en) Para-substituted-3-phenoxy-1-alkoxycarbenyl-alkylamino- propanol-2 compounds
ATE66230T1 (en) NEW PYRROLO-BENZIMIDAZOLES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS.
IT1213173B (en) ANTIBACTERIAL ACTIVITY COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
NO175745C (en) Analogous Process for Preparation of Dibenzo (1,5) -Dioxocin-5-One
AU561393B2 (en) Pharmaceutical preparation treating glaucoma + occular hypotension
IT8026233A0 (en) DERIVATIVE OF N-ACETYL-CYSTEINE WITH THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS.
IL89335A (en) 6-oxo-pyridazine derivatives, a process for their preparation and pharmaceutical compositions containing these compounds
IL85651A (en) Preparation of optically active oxo-isoindolinyl derivatives,some such novel dextrorotary isomers and pharmaceutical compositions containing the novel compounds
IT8721540A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING TRAPIDIL, THEIR PREPARATION PROCEDURE AND THEIR THERAPEUTIC USE.
ZA928126B (en) Use of substituted tetrahydrothiophenes, some of wich are known as medicaments, new active substances and processes for their preparation.
ATE42305T1 (en) ANTIBIOTICS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THEM.